NanoBio Obtains $11,000,000 Series C Financing Round

  • Feed Type
  • Date
    11/29/2012
  • Company Name
    NanoBio
  • Mailing Address
    2311 Green Road Ann Arbor, MI 48105
  • Company Description
    NanoBio Corporation is a biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat technology platform.
  • Website
    http://www.nanobio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $11,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds from the financing will be used to advance the company’s development programs for herpes labialis (cold sores), cystic fibrosis and nanoemulsion-based vaccines for respiratory syncytial virus (RSV) and genital herpes (HSV2).
  • M&A Terms
  • Venture Investor
    Venture Investors
  • Venture Investor
    Merck Capital Ventures
  • Venture Investor
    Perseus

By posting a comment, you agree to our terms and conditions.